Early symptom progression rate is related to ALS outcome: a prospective population-based study.
about
Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron diseaseEnteral tube feeding for amyotrophic lateral sclerosis/motor neuron diseaseRecent advances in amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic TrialsAssociation of lead exposure with survival in amyotrophic lateral sclerosisFactors predicting one-year mortality in amyotrophic lateral sclerosis patients--data from a population-based registryPrognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population.Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.Association of ALS with head injury, cigarette smoking and APOE genotypesSurvival profiles of patients with frontotemporal dementia and motor neuron disease.A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?A systematic review of behavioural changes in motor neuron disease.Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.Study of 962 patients indicates progressive muscular atrophy is a form of ALS.Clinical aspects of ALS in Gulf War veterans.Quantifying disease progression in amyotrophic lateral sclerosis.Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis.Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithmA proposed staging system for amyotrophic lateral sclerosis.Effects of demographic factors on survival time after a diagnosis of amyotrophic lateral sclerosis.Cerebral degeneration predicts survival in amyotrophic lateral sclerosisPositive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities.Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic populationPrognosis of amyotrophic lateral sclerosis with respiratory onset.Prediction of prognosis of ALS: Importance of active denervation findings of the cervical-upper limb area and trunk area.Prognostic value of decreased tongue strength on survival time in patients with amyotrophic lateral sclerosis.Survival of patients with ALS following institution of enteral feeding is related to pre-procedure oximetry: a retrospective review of 98 patients in a single centre.Prognostic factors in ALS: A critical reviewAn open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditionsRespiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclerosis with emphasis upon survival.Capecitabine-induced leukoencephalopathy involving the bilateral corticospinal tractsNutrition and dietary supplements in motor neuron disease.The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onsetDying with motor neurone disease, what can we learn from family caregivers?Long-Term Use of Riluzole Could Improve the Prognosis of Sporadic Amyotrophic Lateral Sclerosis Patients: A Real-World Cohort Study in China.Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of NeurologyTotal laryngectomy in patients with advanced bulbar symptoms of amyotrophic lateral sclerosis.Emerging drugs for amyotrophic lateral sclerosis.Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis.
P2860
Q24234807-ADA23A8E-2BEB-499D-9172-28858024F5D9Q24244143-52668EC4-87E6-4581-A022-517C73AA54BCQ26749521-E77BCE8B-84E7-4BBC-A3DA-F24DE5B695F9Q27021917-9401406C-3972-453E-9D85-6D440F45BAE2Q28384807-39ADE4A4-48A7-4426-9F69-4938E0CC0514Q30857248-34942421-C8D6-4DE2-83ED-408FCA2DE97DQ33516152-85AE8EEB-91B5-41EA-B464-142F803EC8CCQ33609363-0171D4A1-D991-4090-BD23-DD864F2BC584Q33735609-6394241E-0A3C-4304-B1DB-035AAE236071Q33896030-5CF996FE-F574-4C85-B477-B90A1097CA52Q34104378-C9A3E605-C31E-4ADE-9F25-EBACE73B05BDQ34261906-7A4895E3-B333-47FE-8735-1CC574510588Q34375695-68AC1A4B-0E11-4586-9445-35C9157B447DQ34613895-7E5D857F-B328-4791-8C14-39D32AD3426FQ34827410-1355F888-FFC3-4102-8265-476ABAE72822Q35008605-162B96F6-F06C-44D0-8052-1DEA76A3C1D9Q35155099-39929A01-A19F-4E2D-9446-38793A1F5E35Q35747193-A6DC7419-7E4D-40AB-9DD7-70FBFD7DA98DQ35776890-47747D41-992F-4381-A653-A8575185FF6AQ35945013-5361F342-C280-4FE1-A6C0-C0075B29C8CCQ36141891-2DD59A11-88C6-4514-B3EA-D614B766FA76Q36142725-E2C4E1AC-5D4D-42BF-970F-714BDD03D3EAQ36143045-10EAFAE3-68D4-4C9F-92EE-8012135E87C4Q36143806-8E9A43F0-2FED-4F6A-9D73-C0091847BA81Q36322058-55C2792E-09FB-402E-83F5-20DD21E27023Q36357161-B6CCFF38-1755-4171-B863-D762866111D8Q36425117-82F30638-5766-43B9-97C7-B80FFE814046Q36447824-F438ED3E-0F79-4592-B475-2544FA81C0F4Q36551001-4A32EAAE-CDE4-4844-BA49-6AD62EE90344Q36761351-03921841-76B8-428E-AB8E-64F7DED40D2DQ36885192-0976CD43-5E5A-42E6-A24E-879DFBE2A627Q37073851-097A9D5A-2AF1-4DCC-9CB3-89C217CD9755Q37107393-A07CA23A-8623-4EE3-BBC5-93A209B7B130Q37333169-FCC4835A-82D8-4440-8E7B-B72F1B003B93Q37359581-70307683-F85C-4309-9A55-89581D7C067CQ37523903-BA9E07D3-F300-4C6D-9849-50D2EAC78B92Q37613342-B856C854-ECDC-4AE2-A3D5-B4243096EE04Q37634530-2A8BBF10-CB0F-4E56-8150-FCBFFCDEAF9DQ37909351-1738B848-FA6F-42EC-98F6-AD31FE5FB6A0Q37976113-E3BAAA41-70FC-431E-A3DE-EF6F12886495
P2860
Early symptom progression rate is related to ALS outcome: a prospective population-based study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Early symptom progression rate ...... ective population-based study.
@en
type
label
Early symptom progression rate ...... ective population-based study.
@en
prefLabel
Early symptom progression rate ...... ective population-based study.
@en
P2093
P356
P1433
P1476
Early symptom progression rate ...... ective population-based study.
@en
P2093
E Bottacchi
M T Giordana
Piemonte and Valle d'Aosta Register for ALS (PARALS)
P304
P356
10.1212/WNL.59.1.99
P407
P577
2002-07-01T00:00:00Z